ATE405274T1 - Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten - Google Patents

Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten

Info

Publication number
ATE405274T1
ATE405274T1 AT02708676T AT02708676T ATE405274T1 AT E405274 T1 ATE405274 T1 AT E405274T1 AT 02708676 T AT02708676 T AT 02708676T AT 02708676 T AT02708676 T AT 02708676T AT E405274 T1 ATE405274 T1 AT E405274T1
Authority
AT
Austria
Prior art keywords
choriod
remedies
retina
diseases
active ingredients
Prior art date
Application number
AT02708676T
Other languages
English (en)
Inventor
Yasuo Tano
Tatsuji Kurose
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE405274T1 publication Critical patent/ATE405274T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
AT02708676T 2001-03-28 2002-03-27 Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten ATE405274T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001092329 2001-03-28

Publications (1)

Publication Number Publication Date
ATE405274T1 true ATE405274T1 (de) 2008-09-15

Family

ID=18946808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02708676T ATE405274T1 (de) 2001-03-28 2002-03-27 Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten

Country Status (12)

Country Link
US (1) US20040097478A1 (de)
EP (1) EP1380302B1 (de)
KR (1) KR100854058B1 (de)
CN (1) CN100353947C (de)
AT (1) ATE405274T1 (de)
CA (1) CA2442296C (de)
CY (1) CY1108572T1 (de)
DE (1) DE60228431D1 (de)
DK (1) DK1380302T3 (de)
ES (1) ES2311592T3 (de)
PT (1) PT1380302E (de)
WO (1) WO2002078713A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI347847B (en) * 2003-08-20 2011-09-01 Santen Pharmaceutical Co Ltd Drug delivery system for sub-tenon administration of fine particles
US7374219B2 (en) * 2004-09-22 2008-05-20 Zephyros, Inc. Structural reinforcement member and method of use therefor
RU2696045C1 (ru) * 2018-10-15 2019-07-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ лечения болезни Илза
IT201900014052A1 (it) * 2019-08-05 2021-02-05 Lucia Scorolli Preparazione para-bulbare con effetto citotrofico-retinico

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
JPS61106521A (ja) * 1984-10-31 1986-05-24 Kureha Chem Ind Co Ltd 血管増殖抑制剤
DE69032012T2 (de) * 1989-08-28 1998-05-14 Alcon Lab Inc Ophthalmische zubereitung
US5104787A (en) * 1990-03-05 1992-04-14 Lindstrom Richard L Method for apparatus for a defined serumfree medical solution useful for corneal preservation
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
WO1993010141A2 (en) * 1991-11-22 1993-05-27 Alcon Laboratories, Inc. Angiostatic steroids
JPH08503921A (ja) * 1991-12-20 1996-04-30 アメリカ合衆国 カポジ肉腫を処置、及び脈管浸透を阻止又は阻害するための方法
WO1995003807A1 (en) * 1993-07-27 1995-02-09 The University Of Sydney Treatment of age-related macular degeneration
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
AU6763496A (en) * 1995-08-07 1997-03-05 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
ATE493983T1 (de) * 1996-11-05 2011-01-15 Childrens Medical Center Thalidomide und dexamethason für die behandlung von tumors
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6395294B1 (en) * 2000-01-13 2002-05-28 Gholam A. Peyman Method of visualization of the vitreous during vitrectomy
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye

Also Published As

Publication number Publication date
US20040097478A1 (en) 2004-05-20
EP1380302A4 (de) 2006-04-12
KR20030087029A (ko) 2003-11-12
CN1551775A (zh) 2004-12-01
DK1380302T3 (da) 2008-12-08
CN100353947C (zh) 2007-12-12
CY1108572T1 (el) 2014-04-09
PT1380302E (pt) 2008-11-25
ES2311592T3 (es) 2009-02-16
EP1380302A1 (de) 2004-01-14
CA2442296C (en) 2010-06-22
KR100854058B1 (ko) 2008-08-26
WO2002078713A1 (fr) 2002-10-10
CA2442296A1 (en) 2002-10-10
DE60228431D1 (de) 2008-10-02
EP1380302B1 (de) 2008-08-20

Similar Documents

Publication Publication Date Title
JP2010065052A (ja) Ｃｎｓ疾患の治療において使用するためのプレグナンステロイド
RS53329B (en) PROCEDURE AND MIXTURE FOR TREATMENT OF INFLAMMATORY DISORDERS
HRP20050781B1 (hr) Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu
WO2007140791A1 (en) Treatment of cutaneous neurogenic inflammation
WO2002014343A8 (en) Bufadienolide derivatives and use as immunosuppressive, antiinflammatory and analgesic agents
BR0208939A (pt) Método e agente para tratamento oftálmikco tópico de doenças inflamatórias oculares
TW200511996A (en) The use of steroids to treat persons suffering from ocular disorders
ATE405274T1 (de) Heilmittel für erkrankungen der retina und der aderhaut die als aktive bestandteile steroide enthalten
Egarter et al. Hormone replacement therapy with tibolone: effects on sexual functioning in postmenopausal women
Claman Glucocorticosteroids II: the clinical responses
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
DK1343472T3 (da) Thixotropisk næsespray
ATE506061T1 (de) Zusammensetzungen und verfahren zur behandlung, kontrolle, verminderung, verbesserung bzw. prävention von allergien
JP5278313B2 (ja) 輸送体増強コルチコステロイド活性
US5993782A (en) Therapeutic method for reversing hyposmia in a human patient
Berger Treatment update: allergic rhinitis
GB0108865D0 (en) The use of agents to cause intermittent lowering of levels of cortisol and other adrenalhormones as treatment of clinical conditions associated with changes
Albrecht Clinical comparison of methylprednisolone aceponate and prednicarbate in chronic eczema
WO2013002196A1 (ja) 新規医薬組成物
ES2779525T3 (es) Composición que comprende un éster de alfa-tocoferol para prevención y tratamiento de rinitis alérgica
ES2150996T3 (es) Corticoides y composiciones farmaceuticas y cosmeticas.
KR20230031214A (ko) 적응 장애의 치료
CHAVAN et al. Further experimental evaluation of two new corticosteroids: Triamcinolone (Aristocort) and dexamethasone (Deronil) preparations in the therapy of ocular inflammation
WO1992010194A1 (de) Verwendung von antigestagenen zur herstellung von arzneimitteln
KR20210151836A (ko) 편두통의 치료

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1380302

Country of ref document: EP